On the recordSeptember 26, 2016
Jim brought to the DNI an incredible amount of experience throughout the community--a very difficult thing for us to replicate when Jim leaves.
Source
congress.govEditor's note · Context
Burr acknowledges Jim Clapper's invaluable experience as he prepares to retire.
Share & report
More from Richard Burr
Apr 4, 2022
What does it mean for a small company when FDA misses these goals, and what does it mean to patients?
Apr 4, 2022
Why did FDA agree, and why did the industry agree to longer review times of 128 days on 510(k)'s and provide the agency with so much more money?
Jun 15, 2022
I was surprised and frustrated to hear that these funds were overwhelmingly repurposed from within ASPR, including the stockpile.
Apr 4, 2022
More than 278 therapies have been approved under the accelerated approval pathway over the 30 year history, saving and improving thousands of lives.
Other voices in this conversation
